Jpmorgan Chase & CO Prokidney Corp Ord Shs Cl A(Cy Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Jpmorgan Chase & CO holds 53,399 shares of PROK stock, worth $161,264. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,399
Previous 66,415
19.6%
Holding current value
$161,264
Previous $112,000
58.93%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding PROK
# of Institutions
50Shares Held
35.2MCall Options Held
111KPut Options Held
0-
Suvretta Capital Management, LLC New York, NY12.3MShares$37.3 Million0.25% of portfolio
-
Morgan Stanley New York, NY5.99MShares$18.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$11 Million0.0% of portfolio
-
Bleichroeder LP New York, NY2MShares$6.04 Million0.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.57MShares$4.73 Million0.0% of portfolio
About PROKIDNEY CORP ORD SHS CL A(CY
- Ticker PROK
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,540,200
- Market Cap $186M